[[Jeffrey Epstein]] | [[Harvard University]] | [[Harry Fisch]] | [[Bill Gates]] | [[George Chrch]] | [[Richard Kahn]] | [[Darren indyke]] Boris Nikolic is a Croatian-American physician, venture capitalist, and biotechnology investor whose career trajectory — from academic medicine through the Bill and Melinda Gates Foundation to private biotech investment — would be unremarkable as a story of scientific entrepreneurship were it not for a single extraordinary fact: his name appeared in **Jeffrey Epstein's will**, signed on **August 8, 2019** — just **two days before Epstein's death** in the Metropolitan Correctional Center in New York — as the **successor executor of Epstein's estate**. That fact, combined with his deep connections to Bill Gates's scientific philanthropy infrastructure, his positioning at the cutting edge of genomics and synthetic biology investment, and his documented social relationship with Epstein, places Nikolic at one of the most sensitive intersections in the post-Epstein investigation landscape — the junction between Epstein's documented obsession with genetics and reproduction, the Gates Foundation's global health agenda, and the question of what Epstein was attempting to secure or protect in the final days of his life. --- ## Background and Education Nikolic was born in the former **Yugoslavia** — his Croatian background is part of a biographical profile that includes substantial international scientific training before his arrival in American institutional medicine. He trained in medicine and subsequently developed expertise in molecular biology and genetics — the scientific foundation for his later role as a science advisor and biotechnology investor. His academic credentials and scientific literacy placed him in the specific category of physician-scientists that Epstein most assiduously cultivated — people who could bridge the worlds of credentialed institutional science and private capital, who understood both the biology and the investment landscape of emerging biotechnologies. --- ## The Gates Foundation Years Nikolic served as a **science and technology advisor to Bill Gates** and the **Bill and Melinda Gates Foundation** — one of the most powerful private philanthropic organizations in the world, with an endowment that has exceeded $50 billion and a programmatic focus on global health, vaccine development, agricultural development, and more recently pandemic preparedness. His role at the Gates Foundation placed him at the center of the global health investment and research infrastructure — advising on which scientific directions and technologies the Foundation should support, helping evaluate potential grantees and investment targets, and bridging Gates's personal scientific interests with the Foundation's programmatic priorities. This was not a peripheral advisory role — Gates's science advisors have historically had significant influence over the Foundation's strategic directions, and Gates himself is known for deep personal engagement with the scientific and technological dimensions of the Foundation's work. The Gates Foundation's intersection with biotechnology, genomics, and synthetic biology — through its investments in agricultural genomics, vaccine platform technologies, and global health tools — made Nikolic's expertise directly relevant to the Foundation's core work. He was not simply a credentialed ornament but someone whose specific knowledge of emerging biotechnologies aligned with the Foundation's most ambitious programmatic directions. His departure from the Gates Foundation to found **Biomatics Capital** — his own biotech venture capital firm — followed a pattern common among senior foundation figures who transition to private investment, taking their networks, pattern recognition, and institutional knowledge into a for-profit context. The specific timing and circumstances of his departure have not been publicly detailed in ways that would allow confident characterization of whether it was purely voluntary or influenced by any of the complications that subsequently emerged. --- ## Biomatics Capital **Biomatics Capital** is Nikolic's venture capital firm focused on **biotechnology investments** — specifically in the areas of genomics, synthetic biology, digital health, and related fields at the intersection of biology and computation. The firm reflects Nikolic's positioning at the leading edge of what has become one of the most consequential investment categories of the current era — the application of genomic sequencing, CRISPR gene editing, computational biology, and related technologies to medicine, agriculture, and industrial biology. The biotechnology investment landscape Nikolic operates in is both extraordinarily promising and ethically complex — the same technologies that enable treatments for genetic diseases also raise profound questions about human genetic modification, reproductive technology, and the boundaries of biological intervention. This is precisely the territory where Epstein's documented interests — his alleged discussions of human genetic seeding, his funding of various scientific research programs, his cultivation of relationships with leading geneticists and biologists — overlapped with mainstream scientific investment. Biomatics Capital's portfolio and specific investments have not been extensively reported in the public record, making a comprehensive assessment of the firm's activities and direction difficult. What is established is that Nikolic has positioned himself as a serious player in biotech venture capital with the scientific credibility, institutional relationships, and investment thesis to participate in significant deals in this space. --- ## The Epstein Relationship ### How the Relationship Developed Nikolic's relationship with Epstein developed through the same channels that most of Epstein's scientific relationships developed — through the cultivation of scientifically credentialed figures whose proximity enhanced Epstein's intellectual credibility and whose expertise intersected with his documented interests in genetics, reproduction, and human biology. The specific mechanism of introduction has not been established definitively in the public record — whether Nikolic met Epstein through Gates (who had his own Epstein meetings), through scientific circles, or through other social channels is not publicly documented with certainty. What is established is that the relationship was substantive enough that Epstein considered Nikolic a figure of sufficient trust and strategic importance to name him in his will. ### The Nature of the Relationship The documented dimensions of the Nikolic-Epstein relationship include social meetings — Nikolic has acknowledged knowing Epstein — and the will designation. The full scope of their interactions, the content of their discussions, and the nature of any financial or scientific collaboration between them has not been established in the public record with the specificity that would allow confident characterization beyond what has been reported. What can be said with confidence is that Epstein's relationship with Nikolic fit a clear pattern — Epstein specifically and deliberately cultivated relationships with scientists working at the frontier of genetics and reproductive biology. This pattern included his relationships with **George Church** (Harvard geneticist and synthetic biology pioneer), **Martin Nowak** (Harvard evolutionary biologist), **Eric Lander** (geneticist, later Biden's science advisor), and others. Nikolic, with his specific expertise in genomics and biotechnology investment, fit this pattern precisely. --- ## The Will — The Central Mystery ### What the Will Said Jeffrey Epstein's will was signed on **August 8, 2019** — a Thursday. Epstein was found dead on **August 10, 2019** — a Saturday. The two-day interval between signing and death is the fact that has attracted the most attention and generated the most questions. The will placed Epstein's estate — valued at approximately **$577 million** at the time of his death — in a trust. It named **Darren Indyke** and **Richard Kahn**, Epstein's longtime lawyers and financial advisors, as the primary executors. It named **Boris Nikolic as the successor executor** — the person who would take over executor responsibilities if the primary executors could not serve. ### Nikolic's Response Nikolic's public response to learning he had been named in the will was prompt and unambiguous — he said he **had no prior knowledge** of being included, that he had not been asked, and that he **declined to serve** in the successor executor role. His statement to the press was that the designation was made without his knowledge or consent. This response is plausible on its face — wills frequently name successor executors without informing those individuals in advance; it is legally standard practice to name a backup without necessarily consulting them. However, the specific circumstances — the two-day window between signing and death, the apparent deliberateness of Epstein's will preparation in his final days, and the choice of Nikolic specifically — have sustained questions that Nikolic's denial, however credible in isolation, cannot fully resolve. ### Why Nikolic? The question of why Epstein chose Nikolic as successor executor in a will signed two days before his death is the most important unanswered question in Nikolic's connection to the Epstein story. Several interpretations are possible and have been advanced: The most benign interpretation is that Nikolic was simply someone Epstein trusted and respected — a scientifically sophisticated figure who understood Epstein's intellectual interests and could be trusted to manage an estate that included significant scientific funding commitments and research interests. On this reading, the choice was a practical one about competence and trust, with no more sinister implication. A more troubling interpretation is that the will's timing — two days before death — and the specific choice of a Gates Foundation-connected science advisor reflected Epstein's attempt to ensure continuity of specific relationships, projects, or information through someone positioned at the intersection of private science funding and institutional philanthropy. On this reading, Nikolic's role as Gates's former science advisor was not incidental but central to why Epstein chose him — potentially connecting Epstein's estate management to the Gates Foundation's scientific agenda in ways that would benefit from an insider's navigation. The most troubling interpretation — which has been advanced in various forms by journalists and investigators but not established as fact — is that the will's signing two days before death reflects either Epstein's anticipation of his own death or someone else's knowledge of it, and that Nikolic's designation reflects a specific strategic choice about who should control access to information, assets, or relationships in the estate that followed. None of these interpretations is established as fact. The publicly available record supports the first interpretation most directly while not excluding the others. --- ## The Gates Connection and Its Complications ### Bill Gates's Epstein Meetings The Nikolic-Gates-Epstein triangle gained additional complexity from the **documented meetings between Bill Gates and Jeffrey Epstein** that occurred after Epstein's 2008 Florida conviction for soliciting prostitution from a minor — meetings that Gates has acknowledged and described as a mistake. Gates met with Epstein on multiple occasions between approximately 2011 and 2014 — meetings that reportedly included discussions of philanthropic strategy, global health funding, and scientific research priorities. Gates has stated that he was exploring whether Epstein could assist in fundraising for global health initiatives and that he ultimately concluded the relationship was a mistake and terminated it. The meetings between Gates and Epstein occurred during a period when Nikolic was serving as Gates's science advisor — creating the question of whether Nikolic facilitated, attended, or had knowledge of these meetings. The specific relationship between Nikolic's role at the Foundation and the Gates-Epstein meetings has not been fully established in the public record. ### The Gates Divorce Context The **divorce of Bill and Melinda Gates**, announced in May 2021, generated reporting that **Melinda Gates had been deeply uncomfortable with Bill Gates's relationship with Epstein** and that concerns about this relationship were among the factors contributing to the marriage's breakdown. This reporting — from the Wall Street Journal, the New York Times, and other outlets — placed the Gates-Epstein relationship in a domestic context that gave it additional significance and suggested Melinda Gates had expressed concerns that were not adequately addressed. Nikolic's position as a former Gates science advisor whose name appeared in Epstein's will created an awkward triangulation — a figure who connected the Gates institutional world to the Epstein estate in a legally documented way, at a moment when the Gates-Epstein relationship was itself under intense scrutiny. --- ## Scientific Interests and the Epstein Eugenics Allegations ### Epstein's Genetic Obsessions The **New York Times reported in 2019** that Epstein had discussed with scientists a plan to **impregnate women with his sperm** at his New Mexico ranch — an alleged eugenics-adjacent project aimed at seeding humanity with his genetic material. This reporting, based on accounts from scientists who had met with Epstein, placed his cultivation of relationships with geneticists and reproductive specialists in a more disturbing context than mere intellectual curiosity. Epstein funded scientific research through various mechanisms — including donations to Harvard, MIT's Media Lab (which accepted Epstein donations that became a significant scandal for the institution and contributed to **Joi Ito's** resignation as Media Lab director), and private research arrangements. His funding of **evolutionary biology, genetics, and theoretical biology** research positioned him as a patron of the specific sciences most relevant to his alleged genetic interests. ### Nikolic's Position Nikolic's expertise in genomics and biotechnology investment places him squarely in the scientific territory that Epstein was most interested in. This does not establish that Nikolic was aware of or complicit in Epstein's alleged genetic projects — the overlap of expertise could reflect nothing more than Epstein's general cultivation of figures in this field. But it does mean that the relationship between Nikolic and Epstein was not one between a financier with vague scientific interests and a randomly chosen scientist — it was a relationship with specific thematic coherence given both men's positioning in the genetics and biotechnology space. --- ## Key Relationships **Bill Gates** — Nikolic's most significant professional relationship; his role as Gates's science advisor was the institutional foundation of his career trajectory and the connection that makes his Epstein designation most consequential. The Gates-Epstein meetings, the Gates divorce reporting about Melinda Gates's Epstein concerns, and Nikolic's appearance in Epstein's will together constitute a network of connections that the public record has documented without fully explaining. **Jeffrey Epstein** — the relationship whose full dimensions remain unknown; documented through the will designation and social acquaintance; the most significant unresolved question of Nikolic's biography. **George Church** — Harvard geneticist and synthetic biology pioneer with whom Nikolic shares scientific territory; Church also had a documented Epstein relationship, accepting Epstein funding and subsequently expressing regret; the overlap of Nikolic and Church's scientific fields with Epstein's interests illustrates the coherence of Epstein's scientific network. **Darren Indyke and Richard Kahn** — Epstein's primary estate executors named in the same will that named Nikolic as successor; their roles as Epstein's longtime financial and legal advisors and their management of the Epstein estate have been the subject of civil litigation by Epstein's victims.